Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 19Gastrointestinal 6Genitourinary 5Head & Neck 3Other solid neoplasm 2Gynecologic 2

Conditions

Mesothelioma 2

Interventions

Nivolumab 3Ipilimumab 3pembrolizumab 2entrectinib 2cobimetinib 2Pemetrexed 2Cisplatin 2tovorafenib 1sotorasib 1relatlimab 1pralsetinib 1larotrectinib 1ipatasertib 1inavolisib 1daratumumab 1atezolizumab 1alectinib 1PM 01183 1Midazolam 1Carboplatin 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Cisplatin × Other solid neoplasm × Clear all
NCT02784171 2024-12-10

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Canadian Cancer Trials Group

Phase 2/3 Completed
520 enrolled 16 charts 1 FDA
Other solid neoplasmThoracic

Mesothelioma

NCT02899299 2024-05-21

CheckMate743

Bristol-Myers Squibb

Phase 3 Completed
605 enrolled 17 charts 1 FDA
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡